Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 23.34%3.75B | ---- | 9.25%3.04B | ---- | -26.25%2.78B | ---- | 26.92%3.77B | ---- | 35.96%2.97B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 25.91%-173.44M | ---- | -79.18%-234.1M | ---- | ---130.66M | ---- | ---- | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | -164.10%-38.22M | ---- | 12.05%-14.47M | ---- | 50.60%-16.46M | ---- | -27.57%-33.31M | ---- | -1,061.00%-26.11M |
| Impairment and provisions: | ---- | -353.88%-20.1M | ---- | 141.41%7.92M | ---- | -126.53%-19.12M | ---- | -112.26%-8.44M | ---- | 51.43%68.82M |
| -Impairmen of inventory (reversal) | ---- | 131.42%10.04M | ---- | 119.90%4.34M | ---- | -39.48%-21.8M | ---- | -151.64%-15.63M | ---- | -25.54%30.27M |
| -Impairment of trade receivables (reversal) | ---- | -942.11%-30.14M | ---- | 33.30%3.58M | ---- | -62.67%2.69M | ---- | -81.34%7.19M | ---- | 705.81%38.54M |
| Revaluation surplus: | ---- | 20.95%-147.63M | ---- | -20.74%-186.76M | ---- | 32.19%-154.68M | ---- | -12.30%-228.12M | ---- | ---203.13M |
| -Derivative financial instruments fair value (increase) | ---- | 711.12%82.57M | ---- | -139.68%-13.51M | ---- | --34.05M | ---- | ---- | ---- | ---- |
| -Other fair value changes | ---- | -32.87%-230.2M | ---- | 8.20%-173.25M | ---- | 17.27%-188.73M | ---- | -12.30%-228.12M | ---- | ---203.13M |
| Asset sale loss (gain): | ---- | -21.96%5.1M | ---- | 483.35%6.54M | ---- | 88.33%-1.71M | ---- | -182.31%-14.62M | ---- | 13.37%-5.18M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---10.44M | ---- | ---- | ---- | ---20.92M | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -69.94%5.1M | ---- | 1,095.37%16.98M | ---- | -127.09%-1.71M | ---- | 221.61%6.3M | ---- | 13.37%-5.18M |
| Depreciation and amortization: | ---- | 22.37%478.96M | ---- | 8.46%391.39M | ---- | 10.78%360.88M | ---- | 3.19%325.75M | ---- | 6.12%315.69M |
| -Amortization of intangible assets | ---- | 1.75%1.34M | ---- | 1.39%1.32M | ---- | -1.67%1.3M | ---- | 0.00%1.32M | ---- | -0.38%1.32M |
| -Other depreciation and amortization | ---- | -81.33%-13.8M | ---- | -1.52%-7.61M | ---- | 9.51%-7.5M | ---- | -24.08%-8.29M | ---- | -13.19%-6.68M |
| Special items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -97.71%-139M | ---- | -82.37%-70.31M |
| Adjustment items | ---- | -81.33%-13.8M | ---- | -1.52%-7.61M | ---- | 9.51%-7.5M | ---- | -24.08%-8.29M | ---- | -13.19%-6.68M |
| Operating profit before the change of operating capital | ---- | 27.90%3.84B | ---- | 6.74%3B | ---- | -23.28%2.81B | ---- | 20.38%3.66B | ---- | 33.39%3.04B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -211.96%-1.05B | ---- | -181.68%-335.73M | ---- | -97.87%-119.19M | ---- | 89.86%-60.23M | ---- | -300.21%-593.88M |
| Accounts receivable (increase)decrease | ---- | -90.76%-655.01M | ---- | -207.72%-343.37M | ---- | 186.00%318.75M | ---- | 34.45%-370.63M | ---- | -295.24%-565.41M |
| Accounts payable increase (decrease) | ---- | 27.89%774.96M | ---- | 185.61%605.96M | ---- | -224.40%-707.82M | ---- | -67.17%569M | ---- | 467.32%1.73B |
| Special items for working capital changes | ---- | 61.24%-88.56M | ---- | -172.08%-228.49M | ---- | 661.37%316.98M | ---- | -375.86%-56.47M | ---- | -89.40%20.47M |
| Cash from business operations | ---- | 4.54%2.82B | ---- | 3.02%2.7B | ---- | -30.06%2.62B | ---- | 2.95%3.74B | ---- | 8.06%3.64B |
| Other taxs | ---- | -7.59%-655.74M | ---- | 22.13%-609.45M | ---- | -36.11%-782.7M | ---- | -78.08%-575.05M | ---- | 45.14%-322.91M |
| Interest paid - operating | ---- | 16.58%-63.31M | ---- | -36.38%-75.9M | ---- | -22.33%-55.65M | ---- | -26.11%-45.49M | ---- | 24.15%-36.07M |
| Special items of business | 16.35%1.4B | ---- | -5.86%1.21B | ---- | 57.89%1.28B | ---- | -45.16%810.96M | ---- | 20.75%1.48B | ---- |
| Net cash from operations | 16.35%1.4B | 4.41%2.1B | -5.86%1.21B | 13.03%2.01B | 57.89%1.28B | -43.00%1.78B | -45.16%810.96M | -4.70%3.12B | 20.75%1.48B | 20.09%3.28B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -31.32%122.32M | -52.20%193.69M | -25.11%178.1M | 250.86%405.19M | 223.53%237.82M | 2.66%115.48M | -43.32%73.51M | 37.79%112.49M | -21.14%129.7M | 21.61%81.64M |
| Dividend received - investment | --25M | ---- | ---- | ---- | ---- | ---- | ---- | --58.75M | ---- | ---- |
| Loan receivable (increase) decrease | ---- | 8.82%41.08M | ---- | 162.79%37.75M | ---- | -125.76%-60.12M | ---- | 254.40%233.34M | ---- | 112.10%65.84M |
| Decrease in deposits (increase) | ---- | 172.41%607.36M | ---- | -853.49%-838.77M | ---- | 81.35%-87.97M | ---- | 65.21%-471.66M | ---- | -31.00%-1.36B |
| Sale of fixed assets | ---- | -93.63%15.06M | ---- | 1,716.96%236.51M | ---- | -59.13%13.02M | ---- | -64.71%31.85M | ---- | 112.49%90.27M |
| Purchase of fixed assets | -8.35%-632.56M | -5.30%-1.17B | 7.81%-583.81M | 24.07%-1.11B | 0.49%-633.24M | -58.81%-1.47B | -39.43%-636.35M | -44.24%-923.79M | -156.74%-456.39M | -38.89%-640.47M |
| Purchase of intangible assets | ---- | -444.08%-9.38M | ---- | 94.00%-1.72M | ---- | ---28.73M | ---- | ---- | ---- | -11,934.97%-254.66M |
| Sale of subsidiaries | ---- | ---- | ---- | ---22.39M | ---- | ---- | ---- | --29.82M | --14.23M | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---104.15M | ---46.67M | ---- | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | 83.48%-376.12M | -51.78%2.86B | -595.52%-2.28B | -37.67%5.94B | 4.48%459.54M | 12.73%9.52B | --439.84M | -24.90%8.45B | ---- | 29.96%11.25B |
| Cash on investment | ---- | -7.26%-5.62B | ---- | 33.18%-5.24B | ---- | 19.90%-7.84B | ---- | 2.03%-9.79B | ---- | 2.96%-9.99B |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -285.12%-315.68M | ---- |
| Net cash from investment operations | 67.89%-861.36M | -338.73%-3.08B | -15,475.01%-2.68B | -509.77%-701.96M | 114.19%17.45M | 107.56%171.31M | 80.42%-123M | -201.58%-2.27B | -499.53%-628.15M | 78.95%-751.29M |
| Net cash before financing | 136.62%541.08M | -174.64%-978.27M | -213.83%-1.48B | -32.85%1.31B | 88.65%1.3B | 127.42%1.95B | -19.12%687.96M | -66.03%858.31M | -38.45%850.63M | 401.10%2.53B |
| Cash flow from financing activities | ||||||||||
| New borrowing | 152.20%329.25M | -66.81%840.26M | -147.90%-630.75M | 56.66%2.53B | 1,933.14%1.32B | 9.74%1.62B | 67.54%64.76M | 26.06%1.47B | -82.54%38.65M | -17.24%1.17B |
| Refund | ---- | -29.80%-1.58B | ---- | 48.49%-1.22B | ---- | -289.02%-2.36B | ---- | 30.19%-606.91M | ---- | 37.77%-869.37M |
| Dividends paid - financing | -12.40%-1.08B | -24.70%-958.07M | -24.66%-957.74M | 37.71%-768.28M | 37.71%-768.28M | 34.30%-1.23B | 34.09%-1.23B | -204.55%-1.88B | -584.01%-1.87B | -9.91%-616.35M |
| Absorb investment income | ---- | ---- | ---- | ---- | ---- | --27.85M | ---- | ---- | ---- | ---- |
| Net cash from financing operations | 52.29%-757.88M | -416.44%-1.72B | -389.67%-1.59B | 127.85%544.17M | 146.93%548.38M | -93.03%-1.95B | 36.24%-1.17B | -217.47%-1.01B | -3,407.68%-1.83B | 77.10%-318.81M |
| Net Cash | 92.93%-216.8M | -245.58%-2.7B | -266.06%-3.07B | 104,537.11%1.85B | 484.18%1.85B | 98.85%-1.78M | 51.06%-480.57M | -106.97%-153.81M | -173.85%-981.96M | 198.96%2.21B |
| Begining period cash | -49.59%2.75B | 51.65%5.45B | 51.65%5.45B | -0.05%3.59B | -0.05%3.59B | -4.11%3.59B | -4.11%3.59B | 143.53%3.75B | 143.53%3.75B | -59.19%1.54B |
| Cash at the end | 6.25%2.53B | -49.59%2.75B | -56.23%2.38B | 51.65%5.45B | 74.71%5.44B | -0.05%3.59B | 12.57%3.11B | -4.11%3.59B | -3.61%2.76B | 143.53%3.75B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.